Cancel
About Jennifer Jarrett
Jennifer Jarrett is the Chief Operating Officer at Arcus Biosciences and serves on the boards of Syndax Pharmaceuticals and SMART. She has extensive experience in investment banking and has held significant roles at Uber, Medivation, and Citigroup.
Known information
Jennifer Jarrett is the Chief Operating Officer at Arcus Biosciences and serves on the boards of Syndax Pharmaceuticals and SMART, a non-profit organization. She has a rich history of board service, having previously served on the boards of Arena Pharmaceuticals and Audentes Therapeutics. Before her current role, she was Vice President of Corporate Development and Capital Markets at Uber and the Chief Financial Officer of Medivation. Jennifer spent 20 years in investment banking, most recently at Citigroup, where she led the west coast life sciences investment banking practice. Her investment banking career also includes positions at Credit Suisse and Donaldson, Lufkin & Jenrette. Jennifer holds a B.A. in Economics from Dartmouth College and an M.B.A. from Stanford University Graduate School of Business.
About LifeMine Therapeutics
LifeMine Therapeutics is revolutionizing drug discovery by mining genetically-encoded small molecules from the biosphere, utilizing an advanced AI- and genomically-enabled platform.
Report inaccurate information
